Citation: B. Jover et al., Influence of irbesartan and enalapril on changes of renal function associated with the established phase of L-NAME hypertension, J HYPERTENS, 19(11), 2001, pp. 2039-2046
Citation: B. Jover et B. Demeilliers, Angiotensin II type 1 receptor antagonist versus angiotensin I-converting enzyme inhibitor in experimental renal diseases, FUN CL PHAR, 14(6), 2000, pp. 541-548
Citation: A. Herizi et al., Cardiovascular hypertrophy in angiotensin II-induced hypertension. Influence of losartan and bosentan., ARCH MAL C, 93(8), 2000, pp. 983-986
Citation: B. Demeilliers et al., Nitric oxide participates in the renal vasodilatory effect of candesartan in anesthetized rats, J AM S NEPH, 10, 1999, pp. S208-S212
Authors:
Casellas, D
Benahmed, S
Artuso, A
Jover, B
Citation: D. Casellas et al., Candesartan and progression of preglomerular lesions in N-G-nitro-L-arginine methyl ester hypertensive rats, J AM S NEPH, 10, 1999, pp. S230-S233
Citation: Jl. Pasquie et al., Chronic bradykinin infusion and receptor blockade in angiotensin II hypertension in rats, HYPERTENSIO, 33(3), 1999, pp. 830-834